Age-dependent relation of serum sialic acid concentration to aortic pulse wave velocity in type 2 diabetes

Diabetes and Metabolism

Volumn 30, Issue 5, 2004, Pages 441-449

  Wakabayashi, I ^a   Masuda, H ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b Department of Internal Medicine   (Japan)

Author keywords

Acute phase protein; Aging; Atherosclerosis; Cardiovascular risk; Inflammation

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIALIC ACID;

ADULT; AGE DISTRIBUTION; AGED; AORTA; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE MARKER; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PULSE WAVE; SERUM; SYSTOLIC BLOOD PRESSURE;

EID: 10644262293     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70141-6     Document Type: Article

References (34)

1. Ernst E. Fibrinogen: an important risk factor for atherothrombotic diseases. Ann Med, 1994, 26, 15-22.
2. Whicher J, Biasucci L, Rifai N. Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med, 1999, 37, 495-503.
3. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 2001, 103, 1813-8.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362, 801-9.
5. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation, 2002, 105, 1135-43.
6. Lindberg G, Eklund GA, Gullberg B, Rastam L. Serum sialic acid concentration and cardiovascular mortality. BMJ, 1991, 302, 143-6.
7. Lindberg G, Rastam L, Gullberg B, Eklund GA. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol, 1992, 21, 253-7.
8. Crook MA, Earle K, Morocutti A, Yip J, Viberti G, Pickup JC. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care, 1994, 17, 305-10.
9. Tomino Y, Inoue W, Yagame M, Nomoto Y, Sakai H, Ito K, Nagaoka K, Ikeda N. Measurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy. J Diabet Complications, 1988, 2, 175-8.
10. Sakamoto N, Hotta N, Toyota T, Ikeda Y, Matsuoka K, Kasuga M, Kikkawa R. The causes of death in Japanese diabetics based on survey results among 11648 diabetics during 1981-1990. Report of committee on cause of death in diabetes mellitus. J Japan Diab Soc, 1996, 39, 221-36.
11. Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J, 2002, 23, 831-4.
12. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998, 41, 1241-8.
13. Pickup JC, Mattock MB, Crook MA, Chusney GD, Burt D, Fitzgerald AP. Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care, 1995, 18, 1100-3.
14. Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH, Georgino F. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Diabetes Care, 2001, 24, 316-22.
15. Mojiminiyi OA, Abdella N, Moussa MA, Akanji AO, Al Mohammedi H, Zaki M. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract, 2002, 58, 37-44.
16. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke, 2003, 34, 1203-6.
17. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension, 2002, 39, 10-5.
18. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension, 2001, 37, 1236-41.
19. McVeigh GE, Burns DE, Finkelstein SM, McDonald KM, Mock JE, Feske W, Carlyle PF, Flack J, Grimm R, Cohn JN. Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens, 1991, 4, 245-51.
20. Dart AM, Lacombe F, Yeoh JK, Cameron JD, Jennings GL, Laufer E, Esmore DS. Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet, 1991, 338, 270-3.
21. Lehmann ED, Gosling RG, Sonksen PH. Arterial wall compliance in diabetes. Diabet Med, 1992, 9, 114-9.
22. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol, 1994, 140, 669-82.
23. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension, 1999, 33, 1111-7.
24. Gries FA, Koschinsky T. Diabetes and arterial disease. Diabet Med, 1991, 8, 582-7.
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1997, 20, 1183-97.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972, 18, 499-502.
27. Comb DG, Roseman S. The sialic acids. 1. The structure and enzymatic synthesis of N-acetylneuraminic acid. J Biol Chem 1960, 235, 2529-37.
28. Hickler RB. Aortic and large artery stiffness: current methodology and clinical correlations. Clin Cardiol, 1990, 13, 317-22.
29. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology, 1990, 12, 1179-86.
30. Jones RL, Peterson CM. Hematologic alterations in diabetes mellitus. Am J Med, 1981, 70, 339-52.
31. Yokoyama H, Jensen JS, Jensen T, Deckert T. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy. J Intern Med, 1995, 237, 519-23.
32. Crook MA, Couchman S, Tutt P. Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus. Blood Coagul Fibrinolysis, 1996, 7, 586-9.
33. Wakabayashi I, Masuda, H. Relation of serum sialic acid to blood coagulation activity in type 2 diabetes. Blood Coagul Fibrinolysis, 2002, 13, 691-6.
34. Masuda H, Wakabayashi R, Wakabayashi I. Serum sialic acid and ankle versus brachial arterial-pressure ratio in NIDDM. Scand J Clin Lab Invest, 1998, 58, 433-9.